Drug application
FINASTERIDE AND TADALAFIL (FINASTERIDE, TADALAFIL)
Drugs@FDA ANDA 218499 · NOVITIUM PHARMA
Key facts
| Drug name | FINASTERIDE AND TADALAFIL |
|---|---|
| Active ingredients | FINASTERIDE, TADALAFIL |
| Application type | ANDA |
| Application number | 218499 |
| Company | NOVITIUM PHARMA |
| Dosage forms | CAPSULE, ORAL |
| Strength | 5MG;5MG |
| Marketing status | Prescription |
| Reference listed drug | No |
| Latest submission status date | Mar 19, 2025 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.